Panel Discussion: Novel Delivery Modalities & Gene Therapy Approaches in PKD

• Exploring gene therapy, antisense oligonucleotides, and CRISPR-based approaches
• Overcoming delivery barriers to the kidney
• Designing preclinical studies with translational relevance
• Regulatory considerations for first-in-human studies

Speakers:

Maarten Hoek

Senior Vice President & Head Of Research

Maze Therapeutics

Wayne Sackett

Co- Founder & Chief Executive Officer

Estuary Biotherapeutics

Rohini Kalvakuntla

Co-Founder & Chief Business Officer

Helex